Uncertainty of prognosis is one reason patients with hematologic malignancies receive aggressive therapy near end of life more often than those with advanced solid tumors. It is unknown whether end-of ...
In the article that accompanies this editorial, He et al 8 used a machine learning (ML) algorithm to identify patients with advanced cancer who were receiving non–curative-intent treatment and at risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback